Wolfgang Willenbacher
- Oncology top 1%
- Hematology top 1%
- Molecular Biology
- Pathology and Forensic Medicine top 2%
- Genetics top 2%
- Co-authors
- Andrew SpencerVânia HungriaSaroj Vadhan‐RajJianming WangHoward YehFrançois GoldwasserJana PrausováVera Hirsh
- Topics
- Multiple Myeloma Research and Treatments (45 papers)Lymphoma Diagnosis and Treatment (32 papers)Chronic Lymphocytic Leukemia Research (17 papers)
- Partner nations
- AustriaUnited StatesGermany
In The Last Decade
Wolfgang Willenbacher
105 papers receiving 2.8k citations
Hit Papers
Peers
Comparison fields: 5 of 121
- Oncology 1.7k
- Hematology 813
- Molecular Biology 594
- Pathology and Forensic Medicine 545
- Genetics 457
Countries citing papers authored by Wolfgang Willenbacher
This map shows the geographic impact of Wolfgang Willenbacher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wolfgang Willenbacher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wolfgang Willenbacher more than expected).
Fields of papers citing papers by Wolfgang Willenbacher
This network shows the impact of papers produced by Wolfgang Willenbacher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wolfgang Willenbacher. The network helps show where Wolfgang Willenbacher may publish in the future.
Co-authorship network of co-authors of Wolfgang Willenbacher
This figure shows the co-authorship network connecting the top 25 collaborators of Wolfgang Willenbacher. A scholar is included among the top collaborators of Wolfgang Willenbacher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wolfgang Willenbacher. Wolfgang Willenbacher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 3 | |
| 4 | 6 | |
| 5 | 15 | |
| 6 | 6 | |
| 7 | 2 | |
| 8 | 16 | |
| 9 | 29 | |
| 10 | 10 | |
| 11 | 8 | |
| 12 | 127 | |
| 13 | 121 | |
| 14 | Denosumab versus zoledronic acid in bone disease treatment of newly diagnosed multiple myeloma: an international, double-blind, double-dummy, randomised, controlled, phase 3 studybreakdown → | 307 |
| 15 | 22 | |
| 16 | 1 | |
| 17 | 41 | |
| 18 | Long-term control in a patient with refractory multiple myeloma by oral cyclophosphamide and dexamethasone. | 4 |
| 19 | 1 | |
| 20 | 29 |
About Wolfgang Willenbacher
Wolfgang Willenbacher is a scholar working on Hematology, Genetics and Oncology, having authored 112 papers that have together received 2.9k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (45 papers), Lymphoma Diagnosis and Treatment (32 papers) and Chronic Lymphocytic Leukemia Research (17 papers). The work is most often cited by research in Hematology (813 citations), Oncology (1.7k citations) and Orthopedics and Sports Medicine (380 citations). Wolfgang Willenbacher has collaborated with scholars based in Austria, United States and Germany. Frequent co-authors include Andrew Spencer, Vânia Hungria, Saroj Vadhan‐Raj, Jianming Wang, Howard Yeh, François Goldwasser, Jana Prausová, Vera Hirsh, Susie Jun and Giorgio V. Scagliotti. Their work appears in journals such as Journal of Clinical Oncology, Blood and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.